Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
New England Journal of Medicine · 2024
DOI: 10.1056/nejmc2402341 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Elisa Fabbrini und 27 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Research and Development, Raritan, NJ elifabbrini@gmail.com. Hauptthemen laut MEDLINE: Homozygote, RNA, Small Interfering, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 3 Literaturangaben. Gefördert von: Johnson & Johnson Innovative Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Janssen Research and Development, Raritan, NJ elifabbrini@gmail.com.
- Janssen Research and Development, Spring House, PA.
- Janssen Research and Development, Raritan, NJ.
- Arrowhead Pharmaceuticals, Pasadena, CA.
- Janssen Pharmaceutical, Tokyo, Japan.
- Endeavor Clinical Trials, San Antonio, TX.
Förderung
- Johnson & Johnson Innovative Medicine
Zitieren
APA
Fabbrini, E., Rady, B., Koshkina, A., Jeon, J. Y., Ayyar, V. S., Gargano, C., DiProspero, N., Wendel, S., Hegge, J., Hamilton, H., Ding, Z. M., Afrazi, M., Nicholas, A., Pei, T., Nakano, M., Ouchi, S., Saito, Y., Yamashita, A., Tamamura, R., …, & Makimura, H. (2024). Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD. New England Journal of Medicine. https://doi.org/10.1056/nejmc2402341
Vancouver
Fabbrini E, Rady B, Koshkina A, Jeon JY, Ayyar VS, Gargano C, et al. Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD. New England Journal of Medicine. 2024. doi:10.1056/nejmc2402341
BibTeX
@article{Fabbrini2024,
author = {Fabbrini, Elisa and Rady, Brian and Koshkina, Anastasiya and Jeon, Jae Yoon and Ayyar, Vivaswath S and Gargano, Cynthia and DiProspero, Nicholas and Wendel, Susan and Hegge, Julia and Hamilton, Holly and Ding, Zhi-Ming and Afrazi, Maria and Nicholas, Anthony and Pei, Tao and Nakano, Masayoshi and Ouchi, Shohei and Saito, Yuki and Yamashita, Aimi and Tamamura, Ryo and Salazar, Hernan and Shapiro, Craig and Yoshihara, Tatsuya and Yonemura, Takuma and Inoue, Satoshi and Matsuoka, Osamu and Erion, Mark and Pocai, Alessandro and Makimura, Hideo},
title = {Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmc2402341}
}
EUVIMED